HB 2529 (see companion bill SB 241) – Texas
Status: Inactive / DeadYear Introduced: 2023
Link: https://capitol.texas.gov/BillLookup/History.aspx?LegSess=88R&Bill=HB2529
Relating to written notification provided by drug manufacturers regarding the cause of generic or biosimilar insulin prescription drug unavailability.
Return to Database Search
© 2018- The SLIHCQ Database. Initial funding for this project was provided by the Robert Wood Johnson Foundation. The views expressed here do not necessarily reflect the views of the Foundation.
Associated Litigation:
No items found